The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Share News (CLL)

  • There is currently no data for CLL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Genus Finance Director sells 43,000 shares

Wed, 14th Mar 2012 15:32

John Worby, Group Finance Director of Genus, the FTSE 250 animal genetics firm, has sold 43,000 shares, half of the amount he vested earlier this month. Worby sold 43,261 shares at 1,318.41p each for a total of £570,357. The sale was made further to the vesting of 86,523 conditional nil-cost share options on March 5th under the company's performance share plan. The remaining 43,262 share options that vested under the plan have been retained by Worby. Towards the end of last month the firm reported strong growth in sales volumes in Asia has seen animal genetics firm Genus increase revenue by almost a 10th in the first half of its financial year.Furthermore, after reviewing its dividend policy last year, the firm has decided to start paying an interim dividend for the first time this year. The board has approved an interim dividend of 4.5p per share payable on March 30th. The stock has rocketed in the past past year, rising almost 44%, equivalent to 404p. The share price is up 0.84%, or 11p over the past week. Top Director BuysCapital Shopping Centres Group (CSCG) Director name: Mr John Whittaker Amount purchased: 300,000 @ 347.24p Value: £1,041,720Capital Shopping Centres Group (CSCG) Director name: Mr John Whittaker Amount purchased: 300,000 @ 344.55p Value: £1,033,650FBD Holdings (FBH) Director name: Mr Andrew LangfordAmount purchased: 6,818 @ € 9.03 Value: € 61,567Cello Group (CLL) Director name: Mr Mark ScottAmount purchased: 60,500 @ 41.00p Value: £24,805Marks & Spencer Group (MKS) Director name: Ms Miranda CurtisAmount purchased: 5,500 @ 367.50p Value: £20,212BG Group (BG.) Director name: Mr Caio Koch-WeserAmount purchased: 1,000 @ 1,533.14p Value: £15,331BG Group (BG.) Director name: Mr Caio Koch-WeserAmount purchased: 700 @ 1,535.23p Value: £10,747Top Director SellsRolls-Royce Holdings (RR.) Director name: Mr Mike TerrettAmount sold: 287,997 @ 818.25p Value: £2,356,535Barclays (BARC) Director name: Mr Chris LucasAmount sold: 613,536 @ 239.88p Value: £1,471,750Rolls-Royce Holdings (RR.) Director name: Mr Colin P SmithAmount sold: 175,690 @ 818.25p Value: £1,437,583Rolls-Royce Holdings (RR.) Director name: Mr James M GuyetteAmount sold: 113,484 @ 818.25p Value: £928,583Genus (GNS) Director name: Mr John WorbyAmount sold: 43,261 @ 1,318.41p Value: £570,357Sage Group (SGE) Director name: Mr Guy BerruyerAmount sold: 113,925 @ 297.97p Value: £339,462Sage Group (SGE) Director name: Mr Guy BerruyerAmount sold: 105,026 @ 300.00p Value: £315,078Sage Group (SGE) Director name: Mr David ClaytonAmount sold: 72,958 @ 297.97p Value: £217,393Sage Group (SGE) Director name: Mr Paul HarrisonAmount sold: 72,660 @ 297.97p Value: £216,505Rolls-Royce Holdings (RR.) Director name: Mr Mark MorrisAmount sold: 24,846 @ 818.25p Value: £203,302
More News
7 Aug 2020 20:11

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

Read more
4 Aug 2020 09:05

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

Read more
1 Jul 2020 12:10

Arsenal Capital makes £179m offer for Cello Health

(Sharecast News) - Cello Health said on Wednesday it had agreed to a takeover from private venture company Arsenal Capital Partners, valuing the company at £179m.

Read more
13 May 2020 16:18

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
8 Apr 2020 12:53

Wednesday broker round-up

(Sharecast News) - Travis Perkins: JP Morgan downgrades to underweight with a target price of 920p.

Read more
7 Apr 2020 12:47

UK TRADING UPDATE SUMMARY: GCP Student Living Terminates Acquisition

UK TRADING UPDATE SUMMARY: GCP Student Living Terminates Acquisition

Read more
6 Apr 2020 15:17

Access Intelligence Records Widened Annual Loss As Expenses Rise

Access Intelligence Records Widened Annual Loss As Expenses Rise

Read more
18 Mar 2020 14:25

Cello Health Profit Falls On GBP2.7 Million Signal Agency Impairment

Cello Health Profit Falls On GBP2.7 Million Signal Agency Impairment

Read more
11 Mar 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
6 Feb 2020 13:32

Cello Health To Pay GBP1.6 Million Back To Access Intelligence

Cello Health To Pay GBP1.6 Million Back To Access Intelligence

Read more
6 Feb 2020 11:21

Cello Health settles with Access Intelligence over Pulsar sale

(Sharecast News) - Healthcare-focussed advisory group Cello Health updated the market on post-completion adjustments in its sale of the Pulsar platform to Access Intelligence on Thursday.

Read more
16 Jan 2020 12:58

Cello Health Reports "Excellent Year" As Restructures Signal Division

Cello Health Reports "Excellent Year" As Restructures Signal Division

Read more
7 Oct 2019 15:23

Cello Health Secures 11% Holding In Access Intelligence

Cello Health Secures 11% Holding In Access Intelligence

Read more
2 Oct 2019 14:15

Cello Health sells Pulsar business to Access Intelligence

(Sharecast News) - Healthcare-focused advisory group Cello Health has sold its social media analytics software business, Pulsar, to Access Intelligence for £4.5m in shares.

Read more
2 Oct 2019 10:23

Cello Health Sells Social Media Analytics Unit To Access Intelligence

Cello Health Sells Social Media Analytics Unit To Access Intelligence

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.